NSEAnalysts/Institutional Investor Meet/Con. Call Updates2d ago · 23 Sept 2026, 05:15 pm
Analysts/Institutional Investor Meet/Con. Call Updates
Ind-Swift Laboratories Limited · INDSWFTLAB
✦ AI Summary
Ind-Swift Laboratories Limited has informed the Exchange about the schedule of an analyst/institutional investor meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Ind-Swift Laboratories Limited has informed the Exchange about Schedule of meet
Attachments (1)
📄pdf
Download →
INDSWFTLAB_23092026170922_Intimation.pdf
View document text
Ref: ISLL:CH:2026 Date: 23rd September, 2026
The President The Vice President,
Corporate Relationship Department Listing Compliance Department,
BSE Limited National Stock Exchange of India Limited,
Phiroze Jeejeebhoy Towers, Exchange Plaza, 5th Floor
25th Floor, Dalal Street, Plot No. C/2, G-Block,
Mumbai 400 001 Bandra Kurla Complex, Bandra (E),
Mumbai 400 051
BSE Scrip Code: 532305 NSE Symbol: INDSWFTLAB
SUB: Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015
Dear Sir/ Ma’am,
Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and
Disclosure Requirements) Regulations, 2015 we would like to inform, the Schedule of Investor Meet
of the Company as under:
S. DATE TIME COMPANY/INSTITUTION/ TYPE OF MEETING
NO. (IST) ANALYSTS/ORGANIZATION AND MODE
1 Tuesday, 29th 01:00 Arihant Capital Group Meeting and
September, 2026 P.M. Virtual Mode
Note: The schedule of the aforesaid meeting is subject to change. The change may happen due to
exigencies on the part of Analyst / Institutional Investor / Company.
No Unpublished Price Sensitive Information is proposed to be shared by the Company during the
aforesaid Analyst / Investor Meeting.
This disclosure is also being made available on the website of the Company:
https://www.indswiftgroup.com/investor.
Please take the same on the records.
Thanking you,
For IND-SWIFT LABORATORIES LTD.
PARDEEP VERMA
VP-CORPORATE AFFAIRS &
COMPANY SECRETARY